Louisiana 2018 Regular Session

Louisiana Senate Bill SB108

Introduced
2/26/18  
Introduced
2/26/18  
Refer
2/26/18  
Refer
2/26/18  
Refer
3/12/18  
Refer
3/12/18  
Report Pass
4/4/18  
Report Pass
4/4/18  
Engrossed
4/11/18  
Engrossed
4/11/18  
Refer
4/12/18  
Report Pass
4/17/18  
Report Pass
4/17/18  
Enrolled
5/15/18  
Enrolled
5/15/18  
Chaptered
5/25/18  
Chaptered
5/25/18  

Caption

Provides relative to the Medicaid managed care annual report. (gov sig)

Impact

Should SB 108 be enacted, it could significantly reshape the way Medicaid services are administered and evaluated. By instituting stringent reporting protocols, the bill aims to ensure that the Department of Health has a comprehensive understanding of the Medicaid managed care landscape, which can inform future regulatory and funding decisions. This could lead to improved healthcare service delivery for enrollees and also assist in identifying areas needing improvement within the Medicaid program.

Summary

Senate Bill 108 focuses on amending and enacting various provisions concerning the Medicaid managed care program's reporting requirements in Louisiana. The bill mandates the Louisiana Department of Health to submit both annual and quarterly reports regarding the performance and financial metrics of managed care organizations providing Medicaid services. This includes crucial information such as medical loss ratios, expenditure breakdowns on patient care, and the comparison of health outcomes across different organizations. The reporting aims to enhance transparency and accountability within the state's Medicaid program.

Sentiment

Sentiment surrounding SB 108 appears to be largely supportive among legislators focused on maintaining the integrity and efficiency of the Medicaid program. Proponents argue that enhanced reporting will lead to better health outcomes for Medicaid beneficiaries and provide necessary checks on managed care organizations. However, there may be some concerns regarding administrative burdens on the Louisiana Department of Health, and whether the measures could inadvertently complicate the existing frameworks for healthcare providers and patients alike.

Contention

Notable points of contention may arise concerning the implications of increased reporting requirements on healthcare providers and managed care organizations. There could be apprehension about the potential for over-regulation and the impact on operational efficiencies within the managed care systems. Stakeholders may also debate the balance needed to ensure accountability without imposing excessive bureaucratic hurdles that could detract from patient care.

Companion Bills

No companion bills found.

Similar Bills

NJ S3538

Establishes "Equitable Drug Pricing and Patient Access Act."

IN SB0140

Pharmacy benefits.

SC S0342

Pharmacy services

TX HB2658

Relating to the Medicaid program, including the administration and operation of the Medicaid managed care program.

MA S704

Prohibiting discrimination against 340b drug discount program participants

MA H959

Prohibiting discrimination against 340b drug discount program participants

AR HB1354

To Regulate Pharmacy Benefits Managers; To Amend The Law Concerning The State And Public School Life And Health Insurance Program; And To Amend The Law Concerning Certain Health Benefit Plans.

IA SF419

A bill for an act relating to contract pharmacies and covered entities that participate in the 340B drug program.(Formerly SSB 1098.)